4 Results for "

c-MET kinase domain

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "c-MET kinase domain" in MCE Product Catalog:

Cat. No.: HY-124761
CAS No.: 683808-78-8
Research Areas:  

Cancer

Poloppin is a potent, cell penetrant inhibitor of the mitotic Polo-like kinase (PLK) (IC50=26.9 μM) and prevents the protein-protein interaction via the Polo-box domain (PBD) (Kd= 29.5 μM). Poloppin selectively kills cells expressing mutant KRAS, enhancing death in mitosis. Poloppin is used for the study of KRAS-mutant cancers as single agents, or in combination with c-MET inhibitors .
loading...
    loading...
Cat. No.: HY-157551
CAS No.: 940057-42-1
Target:  

JNK c-Met/HGFR

Research Areas:  

Cancer

JNK-IN-16 is a c-Met and JNK inhibitor with nanomolar potency, with IC50 values of 120 nM and 72 nM, respectively. JNK-IN-16 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-183672
Target:  

c-Met/HGFR

Research Areas:  

Cancer

c-Met-IN-28 is a type III allosteric inhibitor of c-MET, with pKi values of 7.4 (WT) and 7.1 (D1228V), and IC50 values of 37 nM (WT) and 72 nM (D1228V) against human c-MET. c-Met-IN-28 can be used for research on c-MET-driven cancers .
loading...
    loading...
Cat. No.: HY-184305
Target:  

c-Met/HGFR

Research Areas:  

Cancer

c-Met-IN-30 is a c-MET inhibitor. c-Met-IN-30 inhibits the proliferation of non-small cell lung cancer, pancreatic ductal adenocarcinoma and triple-negative breast adenocarcinoma, and can be used in the research of the above-mentioned cancers .
loading...
    loading...